Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Dr D Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.